Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn's Disease: A Meta-Analysis of Population-Based Cohorts

被引:168
作者
Tsai, Lester [1 ]
Ma, Christopher [4 ]
Dulai, Parambir S. [1 ]
Prokop, Larry J. [5 ]
Eisenstein, Samuel [3 ]
Ramamoorthy, Sonia L. [3 ]
Feagan, Brian G. [6 ]
Jairath, Vipul [6 ]
Sandborn, William J. [1 ]
Singh, Siddharth [1 ,2 ]
机构
[1] Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Med, Div Biomed Informat, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Surg, Div Colorectal Surg, La Jolla, CA 92093 USA
[4] Univ Calgary, Div Gastroenterol, Calgary, AB, Canada
[5] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN USA
[6] Univ Western Ontario, Div Gastroenterol, London, ON, Canada
基金
美国国家卫生研究院;
关键词
Natural History; Disease Modification; Inflammatory Bowel Diseases; Resection; Tumor Necrosis Factor; INFLAMMATORY-BOWEL-DISEASE; TERM-FOLLOW-UP; 1ST INTESTINAL RESECTION; NATURAL-HISTORY; THIOPURINE TREATMENT; MEDICAL-MANAGEMENT; INCEPTION COHORT; WESTERN HUNGARY; CLINICAL-COURSE; SURGICAL RATES;
D O I
10.1016/j.cgh.2020.10.039
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: We conducted a systematic review with meta-analysis to estimate rates and trends of colectomy in patients with ulcerative colitis (UC), and of primary and re-resection in patients with Crohn's disease (CD), focusing on contemporary risks. METHODS: Through a systematic review until September 3, 2019, we identified population-based cohort studies that reported patient-level cumulative risk of surgery in patients with UC and CD. We evaluated overall and contemporary risk (after 2000) of surgery and analyzed time trends through mixed-effects meta-regression. RESULTS: In patients with UC (26 studies), the overall 1-, 5-, and 10-year risks of colectomy was 4.0% (95% CI, 3.3-5.0), 8.8% (95% CI, 7.7-10.0), and 13.3% (95% CI, 11.3-15.5), respectively, with a decrease in risk over time (P < .001). Corresponding contemporary risks were 2.8% (95% CI, 2.0-3.9), 7.0% (95% CI, 5.7-8.6), and 9.6% (95% CI, 6.3-14.2), respectively. In patients with CD (22 studies), the overall 1-, 5-, and 10-year risk of surgery was 18.7% (95% CI, 15.0-23.0), 28.0% (95% CI, 24.0-32.4), and 39.5% (95% CI, 33.3-46.2), respectively, with a decrease in risk over time (P < .001). Corresponding contemporary risks were 12.3% (95% CI, 10.8-14.0), 18.0% (95% CI, 15.4-21.0), and 26.2% (95% CI, 23.4-29.4), respectively. In a meta-analysis of 8 studies in patients with CD with prior resection, the cumulative risk of a second resection at 5 and 10 years after the first resection was 17.7% (95% CI, 13.5-22.9) and 31.3% (95% CI, 24.1-39.6), respectively. CONCLUSIONS: Patient-level risks of surgery have decreased significantly over time, with a 5-year cumulative risk of surgery of 7.0% in UC and 18.0% in CD in contemporary cohorts. This decrease may be related to early detection and/or better treatment.
引用
收藏
页码:2031 / +
页数:26
相关论文
共 64 条
  • [1] Barnes EL, 2019, GASTROENTEROLOGY, V156, pS155
  • [2] Decreasing Trends in Intestinal Resection and Re-Resection in Crohn's Disease A Nationwide Cohort Study
    Beelen, Evelien M. J.
    van der Woude, C. Janneke
    Pierik, Marie J.
    Hoentjen, Frank
    de Boer, Nanne K.
    Oldenburg, Bas
    van der Meulen, Andrea E.
    Ponsioen, Cyriel I. J.
    Dijkstra, Gerard
    Bruggink, Annette H.
    Erler, Nicole S.
    Schouten, W. Rudolph
    de Vries, Annemarie C.
    [J]. ANNALS OF SURGERY, 2021, 273 (03) : 557 - 563
  • [3] Predictors of the need for second intestinal resection in children with Crohn's disease
    Benchimol, Eric
    Boualit, Medina
    Wong, Jenna
    Colombel, Jean-Frederic
    Gower-Rousseau, Corinne
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 : S6 - S6
  • [4] Changes to Surgical and Hospitalization Rates of Pediatric Inflammatory Bowel Disease in Ontario, Canada (1994-2007)
    Benchimol, Eric I.
    Guttmann, Astrid
    To, Teresa
    Rabeneck, Linda
    Griffiths, Anne M.
    [J]. INFLAMMATORY BOWEL DISEASES, 2011, 17 (10) : 2153 - 2161
  • [5] Risk factors for surgery and postoperative recurrence in Crohn's disease
    Bernell, O
    Lapidus, A
    Hellers, G
    [J]. ANNALS OF SURGERY, 2000, 231 (01) : 38 - 45
  • [6] Long-term Outcome After First Intestinal Resection in Pediatric-onset Crohn's Disease: A Population-based Study
    Boualit, Medina
    Salleron, Julia
    Turck, Dominique
    Fumery, Mathurin
    Savoye, Guillaume
    Dupas, Jean-Louis
    Lerebours, Eric
    Duhamel, Alain
    Merle, Veronique
    Cortot, Antoine
    Colombel, Jean-Frederic
    Peyrin-Biroulet, Laurent
    Gower-Rousseau, Corinne
    [J]. INFLAMMATORY BOWEL DISEASES, 2013, 19 (01) : 7 - 14
  • [7] Decreasing Risk of First and Subsequent Surgeries in Patients With Crohn's Disease in England From 1994 through 2013
    Burr, Nicholas E.
    Lord, Richard
    Hull, Mark A.
    Subramanian, Venkataraman
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (10) : 2042 - +
  • [8] Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study
    Charpentier, Cloe
    Salleron, Julia
    Savoye, Guillaume
    Fumery, Mathurin
    Merle, Veronique
    Laberenne, Jean-Eric
    Vasseur, Francis
    Dupas, Jean-Louis
    Cortot, Antoine
    Dauchet, Luc
    Peyrin-Biroulet, Laurent
    Lerebours, Eric
    Colombel, Jean-Frederic
    Gower-Rousseau, Corinne
    [J]. GUT, 2014, 63 (03) : 423 - 432
  • [9] The Impact of Timing and Duration of Thiopurine Treatment on First Intestinal Resection in Crohn's Disease: National UK Population-Based Study 1989-2010
    Chatu, Sukhdev
    Saxena, Sonia
    Subramanian, Venkataraman
    Curcin, Vasa
    Yadegarfar, Ghasem
    Gunn, Laura
    Majeed, Azeem
    Pollok, Richard C. G.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (03) : 409 - 416
  • [10] The impact of timing and duration of thiopurine treatment on colectomy in ulcerative colitis: a national population-based study of incident cases between 1989-2009
    Chhaya, V.
    Saxena, S.
    Cecil, E.
    Chatu, S.
    Subramanian, V.
    Curcin, V.
    Majeed, A.
    Pollok, R. C.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (01) : 87 - 98